
News|Articles|February 1, 2002
Dutasteride (Dutasteride soft-gelatin capsules), GlaxoSmithKline
NME: 5-alpha reductase inhibitor for treatmentof benign prostatic hyperplasia
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
3
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5


























